This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by De Feo, M. L. Articles by Mannelli, M. Search for Related Content PubMed PubMed Citation Articles by De Feo, M. L. Articles by Mannelli, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB SODIUM

(Hypertension. 1997;29:70.)
© 1997 American Heart Association, Inc.

Research Articles (Issue 1, Part 1)

Urinary Endothelin-1 Excretion Is Enhanced by Low-Dose Infusion of Brain Natriuretic Peptide in Normal Humans

Maria Laura De Feo; Giorgio La Villa; Chiara Lazzeri; Cristina Tosti-Guerra; Angela Becorpi; Cinzia Pupilli; Massimo Mannelli

the Department of Clinical Pathophysiology, Endocrine Unit (M.L. De F., C.P., M.M.); Institute of Internal Medicine, Cardiovascular Unit (G. La V., C.L., C.T.-G.); and Institute of Obstetrics and Gynecology Clinic (A.B.), University of Florence (Italy).

Correspondence to Massimo Mannelli, MD, Department of Clinical Pathophysiology, Endocrine Unit, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy. E-mail m.mannelli@mednuc2.dfc.unifi.it

To evaluate the functional relationship between cardiac natriuretic peptides and endothelin-1 within the human kidney, we studied the effects exerted by infusion of brain natriuretic peptide on urinary endothelin-1 excretion. We studied twice in a single-blind manner five normal volunteers who received a constant infusion of 5% dextrose (250 mL/h) or human brain natriuretic peptide-32 at a dose of 4 pmol/kg per minute. Blood samples were drawn at intervals for measurement of hematocrit and concentrations of creatinine, electrolytes, brain natriuretic peptide, and endothelin-1. Urine was collected at intervals for measurement of flow rate and concentrations of creatinine, sodium, cGMP, and endothelin-1. Blood pressure and heart rate were measured every 15 minutes. Placebo administration did not change blood pressure, heart rate, or any of the other parameters measured in plasma and urine. As expected, brain natriuretic peptide infusion caused significant increases in its own plasma levels (basal versus peak levels [mean±SD], 1.45±0.20 versus 50.5±6.0 pmol/L, P<.01), in urinary cGMP (0.75±0.16 versus 1.92±0.81 fmol/min, P<.05), and in urinary sodium excretion (140.0±38.7 versus 624.2±181.6 µmol/min, P<.01). In addition, it caused an increase in urinary endothelin-1 excretion (4.32±2.11 versus 19.67±9.52 fmol/min, P<.05), without modifying plasma endothelin-1, blood pressure, heart rate, creatinine clearance, and urinary flow rate. Our data indicate that brain natriuretic peptide, at plasma levels comparable to those observed in patients with heart failure, causes a significant increase in urinary but not plasma endothelin-1, thus demonstrating a functional link between cardiac natriuretic peptides and renal release of endothelin-1.

Key Words: brain natriuretic peptide • endothelin • kidney • natriuresis

This article has been cited by other articles:

				K. van der Zander, A. J.H.M. Houben, A. A. Kroon, T. K.A. Wierema, M. J.M.J. Fuss-Lejeune, D. Koster, and P. W. de Leeuw Does Brain Natriuretic Peptide Have a Direct Renal Effect in Human Hypertensives? Hypertension, January 1, 2003; 41(1): 119 - 123. [Abstract] [Full Text] [PDF]